Pritelivir: A Novel Antiviral Revolutionizing Herpes Simplex Virus Treatment
Pritelivir is an innovative antiviral drug developed specifically to treat infections caused by the herpes simplex virus (HSV), including HSV-1 and HSV-2....
Read Moreclinical trials
6 articles tagged with this topic
New Herpes Drug Promises Weekly Pill with High Efficacy
Assembly Biosciences announced a major breakthrough in the treatment of herpes simplex virus (HSV) on August 8, 2025, with the release of highly promising...
Read More
How Herpesviruses Are Becoming Unexpected Heroes in the Fight Against Cancer
Recent research published in May 2025 highlights a groundbreaking new approach to cancer immunotherapy involving the herpes virus, specifically herpesvirus...
Read More
Current State of Herpes Vaccine Research - Will There Be a HSV Vaccine in 2026?
Herpes simplex virus (HSV) infections caused by HSV-1 and HSV-2 affect approximately 3.7 billion people globally—roughly 67% for HSV-1 and 11% for...
Read More
Current State of Herpes Vaccine Research - Will There Be a HSV Vaccine in 2026?
Herpes simplex virus (HSV) infections caused by HSV-1 and HSV-2 affect a significant portion of the global population, causing recurrent painful symptoms and...
Read More
Herpes Vaccine Candidates in 2025: Progress and Prospects
In 2025, the global effort to develop an effective herpes simplex virus (HSV) vaccine is gaining momentum with several promising candidates advancing through...
Read More